Global Kidney Academy - Global Kidney Academy

Global Kidney Academy

Global Kidney Academy

Enhance your nephrology practice with CME and tools focused on kidney medicine.

Popular

Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
MinuteCE®
Personalized Treatment Strategies for Hyperkalemia: Bridging Evidence and Clinical Practice Needs
Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
MinuteCE®
The Edema Question: Selecting a Potassium Binder in Patients With HF or Congestion
Nihar R. Desai, MD, MPH; Pauline A. Swift, PhD
1.00 program credit
- Nihar R. Desai, MD, MPH
- Pauline A. Swift, PhD
1.00 program credit
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
MinuteCE®
From Lab Alert to Action Plan: Monitoring Potassium Without Undermining Cardiorenal Protection
James Burton, DM, FRCP; Pauline A. Swift, PhD
1.00 program credit
- James Burton, DM, FRCP
- Pauline A. Swift, PhD
1.00 program credit
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Nephrology
INFINITY in Focus: Translating New Nonsteroidal MRA Evidence Into Cardiorenal Practice
Peter Rossing, MD, DMSc
- Peter Rossing, MD, DMSc
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Nephrology
FINE-ONE Across the Ages: Evaluating nsMRA Evidence in CKD and Type 1 Diabetes
Katherine Tuttle, MD
- Katherine Tuttle, MD
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
MinuteCE®
The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
1.00 program credit
- Jonathan Barratt, MD, PhD
1.00 program credit
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
MinuteCE®
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
Jonathan Barratt, MD, PhD; An De Vriese, MD, PhD
1.00 program credit
- Jonathan Barratt, MD, PhD
- An De Vriese, MD, PhD
1.00 program credit
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
MinuteCE®
Mechanisms Matter! Optimizing Proteinuria Reduction In IgAN
Chee Kay Cheung, MBChB, MRCP, PhD; Jörg Latus, MD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- Jörg Latus, MD
1.00 program credit

Programs

MinuteCE®
The Potassium Shift: Individualizing Hyperkalemia Management With Modern Oral Potassium Binders
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 credit 8 episodes
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 credit 8 episodes
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
MinuteCE®
Differentiating Oral Potassium Binders: Mechanism, Onset, and Sodium Load
James Burton, DM, FRCP; Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
- James Burton, DM, FRCP
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
MinuteCE®
Hyperkalemia as a Barrier to GDMT: Why “Stopping GDMT” Is Often the Wrong Reflex
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 program credit
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
1.00 program credit
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
MinuteCE®
The Binder Selection Playbook: Matching the Right Strategy to the Right Patient
James Burton, DM, FRCP; Nihar R. Desai, MD, MPH
1.00 program credit
- James Burton, DM, FRCP
- Nihar R. Desai, MD, MPH
1.00 program credit
The Future of IgAN Care
The Future of IgAN Care
MinuteCE®
The Future of IgAN Care
Chee Kay Cheung, MBChB, MRCP, PhD; An De Vriese, MD, PhD
1.00 program credit
- Chee Kay Cheung, MBChB, MRCP, PhD
- An De Vriese, MD, PhD
- Jörg Latus, MD
1.00 program credit
Translating Evidence into IgAN Care
Translating Evidence into IgAN Care
MinuteCE®
Translating Evidence into IgAN Care
Jonathan Barratt, MD, PhD; Jörg Latus, MD
1.00 program credit
- Jonathan Barratt, MD, PhD
- Jörg Latus, MD
1.00 program credit
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
CME/CE
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
- Gianluigi Savarese, MD, PhD, FESC, FHFA
0.25 credits
When Itching Hurts: Quality of Life Disruption in CKD-aP
When Itching Hurts: Quality of Life Disruption in CKD-aP
MinuteCE®
When Itching Hurts: Quality of Life Disruption in CKD-aP
Nancy Helou, PhD; Steven Fishbane, MD
1.00 program credit
- Nancy Helou, PhD
- Steven Fishbane, MD
1.00 program credit

CME

CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
MinuteCE®
CKD, Diabetes, and Albuminuria: Keeping Kidney-Protective Therapy on Board Despite Hyperkalemia
Ellie Kelepouris, MD, FACP, FAHA; Pauline A. Swift, PhD
1.00 program credit
- Ellie Kelepouris, MD, FACP, FAHA
- Pauline A. Swift, PhD
1.00 program credit
Potassium Binders to Optimize GDMT Therapy in HFrEF
Potassium Binders to Optimize GDMT Therapy in HFrEF
MinuteCE®
Potassium Binders to Optimize GDMT Therapy in HFrEF
Nihar R. Desai, MD, MPH; Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
- Nihar R. Desai, MD, MPH
- Ellie Kelepouris, MD, FACP, FAHA
1.00 program credit
What You Don’t See: A Patient’s View of Living with CKD-aP
What You Don’t See: A Patient’s View of Living with CKD-aP
MinuteCE®
What You Don’t See: A Patient’s View of Living with CKD-aP
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
MinuteCE®
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
Winning the CKD-aP Battle: A United Physician-Nurse Front
Winning the CKD-aP Battle: A United Physician-Nurse Front
MinuteCE®
Winning the CKD-aP Battle: A United Physician-Nurse Front
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Gabapentinoids: Safety Considerations and Downstream Outcomes
Gabapentinoids: Safety Considerations and Downstream Outcomes
MinuteCE®
Gabapentinoids: Safety Considerations and Downstream Outcomes
Federico Alberici, MD, PhD; Anastasia Liossatou, PhD, RN
1.00 program credit
- Federico Alberici, MD, PhD
- Anastasia Liossatou, PhD, RN
1.00 program credit
CKD-aP Uncovered Prevalence & Pathophysiology
CKD-aP Uncovered Prevalence & Pathophysiology
MinuteCE®
CKD-aP Uncovered Prevalence & Pathophysiology
Steven Fishbane, MD; Nancy Helou, PhD
1.00 program credit
- Steven Fishbane, MD
- Nancy Helou, PhD
1.00 program credit
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
CME/CE
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD; Julio Núñez, MD, PhD
0.25 credits
- Patrick Rossignol, MD, PhD
- Julio Núñez, MD, PhD
0.25 credits